Envair Electrodyne Limited (BOM:500246)
India · Delayed Price · Currency is INR 44.61
-3.72 (-7.70%)
At close: Mar 9, 2026
Envair Electrodyne Revenue
Revenue
n/a
Revenue Growth
n/a
P/S Ratio
n/a
Revenue / Employee
n/a
Employees
2
Market Cap
206.99M
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Mar 31, 2025 | - | - | - |
| Mar 31, 2024 | 3.97M | -5.75M | -59.14% |
| Mar 31, 2023 | 9.72M | -37.77M | -79.53% |
| Mar 31, 2022 | 47.49M | 39.58M | 500.46% |
| Mar 31, 2021 | 7.91M | -27.01M | -77.35% |
| Mar 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Konark Synthetic | 505.16M |
| Onelife Capital Advisors | 222.47M |
| Global Capital Markets | 30.11M |
| Alfavision Overseas (India) | 13.30M |
| Jolly Plastic Industries | 5.26M |
| Pro Clb Global | 3.15M |
| Transgene Biotek | 2.33M |
| MPIL Corporation | 600.00K |